About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT04720781

The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole

After vonoprazan (20mg/day) or esomeprazole (20mg/day) for 4weeks is prescribed for patients with erosive esophagitis diagnosed by esophagogastroduodenoscopy, the number of patients who will visit our...

Lead sponsor: Showa Inan General Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Showa Inan General Hospital

1. Patients who have erosive esophagitis diagnosed by esophagogastroduodenoscopy is enrolled. 2. Vonoprazan (20mg/day) or esomeprazole (20mg/day) is prescribed for 4weeks the patients randomly without next appointments. 3. Some patients may visit our outpatient clinic again due to some reasons without any appointments. 4. The number of the patients who revisit our outpatient clinic again is compared with vonoprazan group and esomeprazole.

Age

19 - 100 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•outpatients belonging to American Society of Anesthesiologists class I or II
•patients have erosive esophagitis diagnosed by esophagogastroduodenoscopy shortly before the prescription

Exclusion Criteria

•other acid blockers are taken

Related studies

Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction

NCT04411823 · Gastroesophageal Reflux, Sleeve Gastrectomy, and more

RECRUITINGPhase 2

A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old

NCT02616302 · Gastroesophageal Reflux Disease (GERD)

The Influence of Specialized Food Products Based on Ice-Cream on Esophageal Motility

NCT07121803 · Ineffective Esophageal Motility, GERD (Gastroesophageal Reflux Disease)

High Resolution Manometry After Partial Fundoplication for Gastro-oesophageal Reflux

NCT05132816 · Gastroesophageal Reflux, Esophageal Motility Disorders, and more

Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery

NCT06926374 · Colorectal Carcinoma, Rectal Prolapse, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 18, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment300

Start dateJan 2021

Last updatedMay 18, 2025

Condition

Gastroesophageal Reflux

Locations shown

Showa Inan General hospital

Komagane, Nagano

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 18, 2025Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions